SFB-F44 - cell signaling in chronic CNS disorders
Other relevant publications of Alexandra Koschak
2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
2011
Koschak A. (2011)
Impact of gating modulation in CaV1.3 L-type calcium channels.
Channels (Austin). 2010 Nov-Dec;4(6):523-5. Epub 2010 Nov 1. Review.
Baig SM, Koschak A, Lieb A, Gebhart M, Dafinger C, Nürnberg G, Ali A, Ahmad I, Sinnegger-Brauns MJ, Brandt N, Engel J, Mangoni ME, Farooq M, Khan HU, Nürnberg P, Striessnig J, Bolz HJ. (2011)
Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness.
Nat Neurosci. 2011 Jan;14(1):77-84. Epub 2010 Dec 5.
2010
Striessnig J, Bolz HJ, Koschak A. (2010)
Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels.
Pflugers Arch 460:361-74.
Gebhart M, Juhasz-Vedres G, Zuccotti A, Brandt N, Engel J, Trockenbacher A, Kaur G, Obermair GJ, Knipper M, Koschak A, Striessnig J. (2010)
Modulation of Cav1.3 Ca2+ channel gating by Rab3 interacting molecule.
Mol cell Neurosci 44:246-59.
2009
Horak SB, Koschak A, Stuppner H, Striessnig J (2009)
Use-dependent block of voltage-gated Cav2.1 Ca2+ channels by petasins and eudesmol isomers.
J Pharmacol Exp Ther 330: 220-226
2008
Singh A, Gebhart M, Fritsch R, Sinnegger-Brauns MJ, Poggiani C, Hoda JC, Engel J, Romanin C, Striessnig J, Koschak A (2008)
Modulation of voltage- and Ca2+-dependent gating of Cav1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain.
J Biol Chem 283:20733-44.
Watschinger K, Horak SB, Schulze K, Obermair GJ, Wild C, Koschak A, Sinnegger-Brauns MJ, Tampe R, Striessnig J (2008)
Functional properties and modulation of extracellular epitope-tagged Cav2.1 voltage-gated calcium channels.
Channels (Austin) 2, in press
Sinnegger-Brauns MJ, Huber IG, Koschak A, Wild C, Obermair GJ, Einzinger U, Hoda JC, Sartori SB, Striessnig J (2008)
Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms.
Mol Pharmacol, 75: 407-414
Striessnig J, Koschak A (2008)
Exploring the function and pharmacotherapeutic potential of voltage-gated Ca2+ channels with gene knockout models.
Channels (Austin) 2:233-251
2007
Ullrich ND, Koschak A, MacLeod KT (2007)
Oestrogen directly inhibits the cardiovascular L-type Ca2+ channel Cav1.2.
Biochem Biophys Res Commun: 21;361(2):522-7
Koschak A, Obermair GJ, Pivotto F, Sinnegger-Brauns MJ, Striessnig J, Pietrobon D (2007)
Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells.
J Neurosci, 27: 3855-3863
2006
Striessnig J, Koschak A, Sinnegger-Brauns MJ, Hetzenauer A, Nguyen NK, Busquet P, Pelster G, Singewald N (2006)
Role of voltage-gated L-type Ca2+ channel isoforms for brain function.
Biochem Soc Trans 34:903-909
Hoda JC, Zaghetto F, Singh A, Koschak A, Striessnig J (2006)
Effects of congenital stationary night blindness type 2 mutations R508Q and L1364H on Cav1.4 L-type Ca2+ channel function and expression.
J Neurochem 96: 1648-58
Singh A, Hamedinger D, Hoda JC, Gebhart M, Koschak A, Romanin C, Striessnig J (2006)
C-terminal modulator controls Ca2+ -dependent gating of Cav1.4 L-type Ca2+ channels.
Nat Neurosci 9: 1108-1116
2005
Hoda JC, Zaghetto F, Koschak A, Striessnig J (2005)
CSNB2 mutations S229P, G369D, L1068P, and W1440X alter channel gating or functional expression of Cav1.4 L-type Ca2+ channels.
J Neurosci 25: 252-259
